61.65

0.49% -0.28

Livanova Plc (LIVN)

Overview News Price History Option Chain Financials Discussions Forecast

Livanova Plc stock is traded at $61.65, with a volume of 153.82K. It is down -0.49% in the last 24 hours and down -7.23% over the past month. UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Previous Close:

$61.93

Open:

$61.38

24h Volume:

153.82K

Relative Volume:

0.22

Market Cap:

$3.37B

Revenue:

$1.35B

Net Income/Loss:

$-217.48M

P/E Ratio:

-15.37

EPS:

-4.0106

Net Cash Flow:

$191.43M

1W Performance:

-5.57%

1M Performance:

-7.23%

6M Performance:

+7.48%

1Y Performance:

+57.78%

1-Day Range:

$60.89

$62.16

1-Week Range:

$60.62

$64.94

52-Week Range:

$32.48

$71.92

Livanova Plc Stock (LIVN) Company Profile

Name

Livanova Plc

Sector

Healthcare (1117)

Industry

Medical Devices (139)

Phone

4402033250662

Address

20 EASTBOURNE TERRACE, LONDON

Employee

3,300

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

LIVN's Discussions on Twitter

Compare LIVN vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LIVN Livanova Plc	61.62	3.39B	1.35B	-217.48M	191.43M	-4.0106
ABT Abbott Laboratories	110.21	192.10B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	343.37	137.25B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	89.00	115.41B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	68.86	103.81B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	84.64	49.82B	6.07B	1.06B	1.34B	1.8063

Livanova Plc Stock (LIVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-19-25	Initiated	KeyBanc Capital Markets	Overweight
Oct-01-25	Downgrade	Goldman	Buy → Neutral
May-20-25	Upgrade	Wolfe Research	Peer Perform → Outperform
Feb-26-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Oct-04-24	Initiated	Goldman	Buy
Sep-17-24	Upgrade	Robert W. Baird	Neutral → Outperform
Mar-20-24	Reiterated	Needham	Buy
Feb-20-24	Upgrade	Mizuho	Neutral → Buy
Sep-06-23	Initiated	HSBC Securities	Hold
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-14-23	Initiated	Mizuho	Neutral
Dec-21-22	Initiated	Barclays	Equal Weight
Apr-06-22	Initiated	Wolfe Research	Outperform
Feb-24-22	Upgrade	UBS	Neutral → Buy
Dec-03-21	Initiated	Goldman	Buy
Aug-20-21	Reiterated	Needham	Buy
Jul-20-21	Upgrade	Needham	Hold → Buy
Mar-03-21	Downgrade	Berenberg	Buy → Hold
Jan-05-21	Downgrade	Needham	Buy → Hold
Sep-02-20	Initiated	Robert W. Baird	Outperform
Jun-26-20	Reiterated	Needham	Buy
Oct-30-19	Reiterated	Needham	Buy
Feb-28-19	Reiterated	Needham	Buy
Nov-28-18	Initiated	UBS	Neutral
Aug-02-18	Reiterated	Needham	Buy
Jun-08-18	Initiated	Stifel	Buy
May-31-18	Reiterated	Needham	Buy
Feb-28-18	Reiterated	Needham	Buy

View All

Livanova Plc Stock (LIVN) Latest News

Mar 08, 2026

Trading Systems Reacting to (LIVN) Volatility - Stock Traders Daily

Mar 08, 2026

Mar 07, 2026

American Century Companies Inc. Buys 175,570 Shares of LivaNova PLC $LIVN - MarketBeat

Mar 07, 2026

Mar 06, 2026

Sentiment Recap: Is LivaNova PLC being accumulated by smart money2025 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 06, 2026

Mar 05, 2026

All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy - Yahoo Finance

Mar 05, 2026

Vanguard Group Inc. Lowers Holdings in LivaNova PLC $LIVN - MarketBeat

Mar 05, 2026

Mar 04, 2026

Rock Point Advisors LLC Makes New Investment in LivaNova PLC $LIVN - MarketBeat

Mar 04, 2026

Mar 03, 2026